Literature DB >> 21484111

Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C.

Shunsuke Sato1, Takuya Genda2, Katsuharu Hirano2, Hironori Tsuzura2, Yoshio Kanemitsu2, Yutaka Narita2, Tetsu Kikuchi2, Katsuyori Ijima2, Takafumi Ichida2.   

Abstract

PURPOSE: The serum hepatitis C virus (HCV) load is persistently stable in patients with untreated chronic hepatitis C, but its differences between individuals vary widely (above 4 logU/mL). Because serum viral load is an important factor for predicting clinical outcome of interferon-based antiviral therapy, this study was performed to clarify the factors associated with serum viral load in chronic hepatitis C patients.
METHODS: We retrospectively analyzed data from 669 chronic hepatitis C patients with HCV genotype 1 or 2 infection. Stepwise regression analysis was used to estimate the relationship between demographic, viral, or biochemical variables and serum viral load.
RESULTS: In univariate analysis, serum lipid profiles, such as total cholesterol, low-density lipoprotein (LDL) and triglyceride levels, and hemoglobin A1c (HbA1c) were correlated with the serum HCV viral load. In multivariate analysis, HCV genotype 1 infection and higher total cholesterol levels were associated with higher viral load. After stratification by HCV genotype, the serum viral load was associated with triglyceride and HbA1c in genotype 1 and with platelet counts and LDL in genotype 2. Histological data (413 patients) showed correlation between severe liver fibrosis and decreased serum viral load in patients with HCV genotype 2 but not genotype 1 infection.
CONCLUSIONS: These results suggest that viral kinetics is affected by different host factors for genotypes 1 and 2.

Entities:  

Keywords:  Genotype; Hepatitis C virus; Low-density lipoprotein; Triglyceride; Viral load

Year:  2011        PMID: 21484111     DOI: 10.1007/s12072-011-9273-z

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  37 in total

1.  Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.

Authors:  A Berger; M von Depka Prondzinski; H W Doerr; H Rabenau; B Weber
Journal:  J Med Virol       Date:  1996-04       Impact factor: 2.327

2.  Serum lipid pattern in chronic hepatitis C: histological and virological correlations.

Authors:  D Siagris; M Christofidou; G J Theocharis; N Pagoni; C Papadimitriou; A Lekkou; K Thomopoulos; I Starakis; A C Tsamandas; C Labropoulou-Karatza
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

3.  Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.

Authors:  L Fanning; E Kenny; M Sheehan; B Cannon; M Whelton; J O'Connell; J K Collins; F Shanahan
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

4.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.

Authors:  Sharookh B Kapadia; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

6.  Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Authors:  Jin Ye; Chunfu Wang; Rhea Sumpter; Michael S Brown; Joseph L Goldstein; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

7.  Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.

Authors:  Ching-Sheng Hsu; Chen-Hua Liu; Chun-Jen Liu; Chia-Chi Wang; Chi-Ling Chen; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Am J Gastroenterol       Date:  2009-02-10       Impact factor: 10.864

Review 8.  Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.

Authors:  Shinya Maekawa; Nobuyuki Enomoto
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

9.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

10.  Relationship of hepatitis C virus genotypes and viremia levels with development of hepatocellular carcinoma among Japanese.

Authors:  K Tanaka; T Hirohata
Journal:  Fukuoka Igaku Zasshi       Date:  1998-08
View more
  1 in total

1.  Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2.

Authors:  Nobuyoshi Seki; Tomonori Sugita; Yuta Aida; Munenori Itagaki; Haruya Ishiguro; Satoshi Sutoh; Hiroshi Abe; Akihito Tsubota; Masato Matsushima; Yoshio Aizawa
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.